Publicaciones en colaboración con investigadores/as de KU Leuven (12)

2015

  1. Functional MMP-10 is required for efficient tissue repair after experimental hind limb ischemia

    FASEB Journal, Vol. 29, Núm. 3, pp. 960-972

2014

  1. Targeting VEGFR1 on endothelial progenitors modulates their differentiation potential

    Angiogenesis, Vol. 17, Núm. 3, pp. 603-616

2013

  1. PHD2 regulates arteriogenic macrophages through TIE2 signalling

    EMBO Molecular Medicine, Vol. 5, Núm. 6, pp. 843-857

2012

  1. Gene-Targeting of Phd2 Improves Tumor Response to Chemotherapy and Prevents Side-Toxicity

    Cancer Cell, Vol. 22, Núm. 2, pp. 263-277

2011

  1. Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis

    Nature, Vol. 479, Núm. 7371, pp. 122-126

2010

  1. From vessel sprouting to normalization: Role of the prolyl hydroxylase domain protein/hypoxia-inducible factor oxygen-sensing machinery

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 30, Núm. 12, pp. 2331-2336

  2. Loss or Silencing of the PHD1 Prolyl Hydroxylase Protects Livers of Mice Against Ischemia/Reperfusion Injury

    Gastroenterology, Vol. 138, Núm. 3

  3. Short-term delivery of anti-PlGF antibody delays progression of atherosclerotic plaques to vulnerable lesions

    Cardiovascular Research, Vol. 86, Núm. 1, pp. 29-36

2009

  1. Development of targeted angiogenic medicine

    Journal of Thrombosis and Haemostasis, Vol. 7, Núm. 1, pp. 21-33

2008

  1. Beneficial effects of prolonged systemic administration of PIGF on late outcome of post-ischaemic myocardial performance

    Journal of Pathology, Vol. 216, Núm. 2, pp. 236-244

  2. Genetics, epigenetics and pharmaco-(epi)genomics

    Journal of Cellular and Molecular Medicine, Vol. 12, Núm. 6B, pp. 2533-2551

2007

  1. Myocardial hypertrophy in the absence of external stimuli is induced by angiogenesis in mice

    Journal of Clinical Investigation, Vol. 117, Núm. 11, pp. 3188-3197